Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aventis Allegra Once-Daily New Prescription Market Share Reaches 13%

Mar 05 2001

• By The Pink Sheet

Related Content

Schering-Plough Clarinex NDA Approval Awaits Resolution Of GMP Problems

Feb 19 2001

Claritin Supply Sufficient For Spring, Schering Says; FDA Lists GMP Problems

Mar 05 2001

Schering Desloratadine Launch Ads In U.K. Include Decongestant Claim

Feb 12 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window